Second-line therapy in testicular germ cell tumours: results from a tertiary cancer care centre in India

BACKGROUND: Malignant testicular neoplasms constitute about 1% of all cancers in males. This is one of the most common tumours in adolescents and young adult males. After the introduction of cisplatin-based chemotherapy, the survival of germ cell tumour patients, even those with poor prognostic risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Amit, Kalra, Devanshi, Simha, Vijai, Menon, Nandini, Noronha, Vanita, Bakshi, Ganesh, Prakash, Gagan, Pal, Mahendra, Murthy, Vedang, Menon, Santosh, Sable, Nilesh, Agrawal, Archi, Rane, Pallavi, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377817/
https://www.ncbi.nlm.nih.gov/pubmed/36072230
http://dx.doi.org/10.3332/ecancer.2022.1408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377817/
https://www.ncbi.nlm.nih.gov/pubmed/36072230
http://dx.doi.org/10.3332/ecancer.2022.1408

Ejemplares similares